NCT02705469 - A Study of ZEN003694 in Patients With Metastatic Castration-Resistant Prostate Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions

Metastatic Castration-Resistant Prostate Cancer

Interventions

DRUG

ZEN003694

Trial Locations (8)

University of California Los Angeles Medical Center, Los Angeles

University of California San Francisco Medical Center, San Francisco

Karmanos Cancer Institute, Detroit

Karmanos Cancer Institute, Farmington Hills

Memorial Sloan Kettering Cancer Center, New York

Oregon Health & Science University, Portland

Virginia Oncology Associates, Hampton

Virginia Oncology Associates, Norfolk